Name | Idarucizumab |
---|
Description | Idarucizumab is a humanized monoclonal antibody fragment. Idarucizumab is first reversal agent for a direct oral anticoagulant (DOAC). Idarucizumab can specifically neutralize the effects of the oral direct thrombin inhibitor in order to restore hemostasis[1]. |
---|---|
Related Catalog | |
References |
No Any Chemical & Physical Properties |